The company
AIM ImmunoTech Inc.
AIM · NYSE American
We hold no 150-day reading for AIM yet: it needs about 200 sessions of history. Biotechnology: 17% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 27% (−6 points in four weeks).
Statistics
- Last close, 23 Oct 2026
- 0.16 −2.92%
- 52-week range
- —
- Volume
- 0.92M
- Average volume (50 days)
- —
- Relative volume
- —
- Rotation
- not in the set
- Weeks in an uptrend
- —
- Industry in uptrend
- 17% -9 in 4 wk
- Insider buys, 12 months
- $32K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 15 (+0)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Price and volume
Daily bars to 23 Oct 2026: 30 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Thomas K. EquelsCEO & President | bought | 31,250at $0.163 | 22 Oct 2026filed 23 Oct 2026 |
| Thomas K. EquelsCEO & President | bought | 24,000at $0.208 | 17 Sep 2026filed 18 Sep 2026 |
| Thomas K. EquelsCEO & President | bought | 11,000at $0.21 | 16 Sep 2026filed 17 Sep 2026 |
| Thomas K. EquelsCEO & President | bought | 22,000at $0.221 | 15 Sep 2026filed 16 Sep 2026 |
| Thomas K. EquelsCEO & President | bought | 5,900at $0.219 | 14 Sep 2026filed 15 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 807,885$229K | +787,838+3930.0% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 50,864$14K | +50,000+5787.0% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 46,003$13K | +16,085+53.8% |
| GOLDMAN SACHS GROUP INCnew · filed 14 Aug 2026 | 32,444$9,214 | +32,444 |
| UBS Group AGadded · filed 13 Aug 2026 | 28,931$8,216 | +28,930+2893000.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 2026 | 21,859$6,208 | +21,859 |
| VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026 | 17,519$4,975 | 00.0% |
| Ground Swell Capital, LLCnew · filed 5 Aug 2026 | 12,222$3,471 | +12,222 |
| Tower Research Capital LLC (TRC)unchanged · filed 11 Aug 2026 | 4,668$1,326 | 00.0% |
| Continuum Advisory, LLCnew · filed 6 Aug 2026 | 500$142 | +500 |
News
Everyone who traded it
Same industry
No other stock in its industry this week.
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.